Informationen:
Fehler:
ID
12814
Beschreibung
An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT01662310
Link
https://clinicaltrials.gov/show/NCT01662310
Stichworte
Versionen (1)
- 21.12.15 21.12.15 -
Hochgeladen am
21. Dezember 2015
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Schizophrenia NCT01662310
Eligibility Schizophrenia NCT01662310
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Schizophrenia NCT01662310
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
dsm-iv
Item
have a diagnosis of schizophrenia according to diagnostic and statistical manual of mental disorders, 4th edition (dsm-iv)
boolean
C0220952 (UMLS CUI [1])
Acute Psychotic Episode; Positive and negative syndrome scale
Item
have experienced an acute episode, with a positive and negative syndrome scale (panss) total score between 70 and 120 inclusive, at screening and baseline
boolean
C0237811 (UMLS CUI [1])
C0451383 (UMLS CUI [2])
C0451383 (UMLS CUI [2])
Infertility; hysterectomy; contraceptive methods
Item
women must be postmenopausal (for at least 1 year), surgically sterile (have had a hysterectomy or bilateral oophorectomy, tubal ligation, or otherwise be incapable of pregnancy), practicing a highly effective method of birth control, if sexually active
boolean
C0021359 (UMLS CUI [1])
C0020699 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
C0020699 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
Contraceptive methods; Sperm donation
Item
men must be using a highly effective method of birth control and must not donate sperm during the study and for 3 months after receiving the last dose of study drug
boolean
C0700589 (UMLS CUI [1])
C0871414 (UMLS CUI [2])
C0871414 (UMLS CUI [2])
compliance behavior
Item
be willing and capable to complete the questionnaires and able to take oral medications independently
boolean
C1321605 (UMLS CUI [1])
dsm-iv; drug dependence
Item
has drug dependence diagnosis according to dsm-iv (excluding nicotine and caffeine dependence) within 6 months before screening
boolean
C0220952 (UMLS CUI [1])
C1510472 (UMLS CUI [2])
C1510472 (UMLS CUI [2])
Crohn Disease; renal diseases; hepatic disease
Item
participants with crohn's disease and hepatic or renal diseases
boolean
C0010346 (UMLS CUI [1])
C0022658 (UMLS CUI [2])
C0023895 (UMLS CUI [3])
C0022658 (UMLS CUI [2])
C0023895 (UMLS CUI [3])
comorbidity
Item
has had relevant history of any significant and/or unstable cardiovascular, respiratory, neurologic (including seizures or significant cerebrovascular dysfunction), renal, hepatic, endocrine, or immunologic diseases
boolean
C0009488 (UMLS CUI [1])
neuroleptic malignant syndrome
Item
has had history of neuroleptic malignant syndrome (the disorder caused by antipsychotic drugs with symptoms of fever, muscle rigidity and delirium)
boolean
C0027849 (UMLS CUI [1])
stevens johnson syndrome; phenytoin
Item
has had known or suspected stevens johnson syndrome (an immune disease with symptoms of fever, sore throat, ulcers and conjunctivitis) after exposure to phenytoin, carbamazepine, barbiturates, or lamotrigine
boolean
C0038325 (UMLS CUI [1])
C0031507 (UMLS CUI [2])
C0031507 (UMLS CUI [2])
Treatment-resistant schizophrenia; clozapine
Item
had been treated with clozapine for treatment refractory or treatment resistant schizophrenia
boolean
C3544321 (UMLS CUI [1])
C0009079 (UMLS CUI [2])
C0009079 (UMLS CUI [2])
behavior suicide; behavior homicidal
Item
has significant risk of suicide or homicidal behavior, or significant risk of deliberate self harm or harm to others
boolean
C0004927 (UMLS CUI [1,1])
C0038661 (UMLS CUI [1,2])
C0004927 (UMLS CUI [2,1])
C0745031 (UMLS CUI [2,2])
C0038661 (UMLS CUI [1,2])
C0004927 (UMLS CUI [2,1])
C0745031 (UMLS CUI [2,2])
isocarboxazid; phenelzine
Item
has taken isocarboxazid, phenelzine, selegiline and tranylcypromine within 4 weeks before screening
boolean
C0022154 (UMLS CUI [1])
C0031392 (UMLS CUI [2])
C0031392 (UMLS CUI [2])
electroconvulsive therapy
Item
has received electroconvulsive therapy within 60 days before screening
boolean
C0013806 (UMLS CUI [1])